A critical role of neural-specific JNK3 for ischemic apoptosis

Kuan, Chia Yi; Whitmarsh, Alan J.; Yang, Derek D.; Liao, Guanghong; Schloemer, Aryn; Dong, Chen; Bao, Jue; Banasiak, Kenneth; Haddad, Gabriel G.; Flavell, Richard A.; Davis, Roger J.; Rakić, Paško

doi:10.1073/pnas.2336254100

Cited by 374 publications

(326 citation statements)

References 46 publications

Supporting

Mentioning

311

Contrasting

Order By: Relevance

“…Evidence in support of this idea is, however, rather lacking. Seizures do not trigger a notably different spatiotemporal p53 or JNK response compared with ischemia, and accumulation/activation of the three BH3-only proteins is also not particularly different (Culmsee et al, 2001;Gao et al, 2005;Kuan et al, 2003;Luo et al, 2009). (5) The temporal ordering of the BH3-only responses.…”

Section: Mechanistic Basis For Differing Causal Roles Of Bcl-2 Homolomentioning

confidence: 99%

In vivoContributions of BH3-Only Proteins to Neuronal Death Following Seizures, Ischemia, and Traumatic Brain Injury

Engel

Plesnila

Prehn

et al. 2011

J Cereb Blood Flow Metab

View full text Add to dashboard Cite

The Bcl-2 homology (BH) domain 3-only proteins are a proapoptotic subgroup of the Bcl-2 gene family, which regulate cell death via effects on mitochondria. The BH3-only proteins react to various cell stressors and promote cell death by binding and inactivating antiapoptotic Bcl-2 family members and direct activation of proapoptotic multi-BH domain proteins such as Bax. Here, we review the in vivo evidence for their involvement in the pathophysiology of status epilepticus and contrast it to ischemia and traumatic brain injury. Seizures in rodents activate three potent proapoptotic BH3-only proteins: Bid, Bim, and Puma. Analysis of damage after seizures in mice singly deficient for each BH3-only protein supports a causal role for Puma and to a lesser extent Bim but, surprisingly, not Bid. In ischemia and trauma, where core aspects of the pathophysiology of cell death overlap, multiple BH3-only proteins are also activated and Bid has been shown to be required for neuronal death. The findings suggest that while each neurologic insult activates multiple BH3-only proteins, there may be specificity in their functional contribution. Future challenges include evaluating the remaining BH3-only proteins, explaining different causal contributions, and, if possible, exploring neurologic outcomes in mouse models deficient for multiple BH3-only proteins.

show abstract

Section: Mechanistic Basis For Differing Causal Roles Of Bcl-2 Homolomentioning

confidence: 99%

In vivoContributions of BH3-Only Proteins to Neuronal Death Following Seizures, Ischemia, and Traumatic Brain Injury

Engel

Plesnila

Prehn

et al. 2011

J Cereb Blood Flow Metab

View full text Add to dashboard Cite

show abstract

“…Of the three isoforms of JNK (JNK1, JNK2 and JNK3), JNK3 is expressed in neurons and JNK1 is expressed in non-neuronal cells (e.g. immune cells) (Ip and Davis 1998;Borsello et al, 2003;Kuan et al, 2003). JNK1 is also expressed in spinal astrocytes and only this isoform is hyperphosphorylated in the spinal cord after SNL (Zhuang et al, 2006a).…”

Section: Activation Of the Jnk Cascade In Spinal Astrocytes And Neuromentioning

confidence: 99%

Possible role of spinal astrocytes in maintaining chronic pain sensitization: review of current evidence with focus on bFGF/JNK pathway

et al. 2006

View full text Add to dashboard Cite

Although pain is regarded traditionally as neuronally mediated, recent progress shows an important role of spinal glial cells in persistent pain sensitization. Mounting evidence has implicated spinal microglia in the development of chronic pain (e.g. neuropathic pain after peripheral nerve injury). Less is known about the role of astrocytes in pain regulation. However, astrocytes have very close contact with synapses and maintain homeostasis in the extracellular environment. In this review, we provide evidence to support a role of spinal astrocytes in maintaining chronic pain. In particular, cJun N-terminal kinase (JNK) is activated persistently in spinal astrocytes in a neuropathic pain condition produced by spinal nerve ligation. This activation is required for the maintenance of neuropathic pain because spinal infusion of JNK inhibitors can reverse mechanical allodynia, a major symptom of neuropathic pain. Further study reveals that JNK is activated strongly in astrocytes by basic fibroblast growth factor (bFGF), an astroglial activator. Intrathecal infusion of bFGF also produces persistent mechanical allodynia. After peripheral nerve injury, bFGF might be produced by primary sensory neurons and spinal astrocytes because nerve injury produces robust bFGF upregulation in both cell types. Therefore, the bFGF/JNK pathway is an important signalling pathway in spinal astrocytes for chronic pain sensitization. Investigation of signaling mechanisms in spinal astrocytes will identify new molecular targets for the management of chronic pain.

show abstract

“…They then proved in a cell-free assay that the JBD 20 sequence prevented interactions and phosphorylations by JNK of nine of these targets. Among these nine substrates, we have studied the following four that might participate in regulating the death of cortical neurons: (1) MADD/DENN (MAPK-activating death domain-containing protein/differentially expressed in normal and neoplastic cells); (2-3) mitogen-activated protein kinase kinase 4 (MKK4) and mitogen-activated protein kinase kinase 7 (MKK7), the two direct upstream activators of JNK and (4) the scaffold protein IB1/JIP-1.,In particularly, MADD/DENN was identified as a substrate for JNK3, 10 the isoform most clearly involved in excitotoxicity 11,12 and mostly expressed in the brain. [10][11][12] Increasing evidence supports a strong correlation between low MADD/ DENN expression and neuronal loss.…”

mentioning

confidence: 99%

“…In particularly, MADD/DENN was identified as a substrate for JNK3, 10 the isoform most clearly involved in excitotoxicity 11,12 and mostly expressed in the brain. [10][11][12] Increasing evidence supports a strong correlation between low MADD/ DENN expression and neuronal loss.…”

mentioning

confidence: 99%

See 1 more Smart Citation

Role of the JNK pathway in NMDA-mediated excitotoxicity of cortical neurons

et al. 2006

View full text Add to dashboard Cite

Excitotoxic insults induce c-Jun N-terminal kinase (JNK) activation, which leads to neuronal death and contributes to many neurological conditions such as cerebral ischemia and neurodegenerative disorders. The action of JNK can be inhibited by the Dretro-inverso form of JNK inhibitor peptide (D-JNKI1), which totally prevents death induced by N-methyl-D-aspartate (NMDA) in vitro and strongly protects against different in vivo paradigms of excitotoxicity. To obtain optimal neuroprotection, it is imperative to elucidate the prosurvival action of D-JNKI1 and the death pathways that it inhibits. In cortical neuronal cultures, we first investigate the pathways by which NMDA induces JNK activation and show a rapid and selective phosphorylation of mitogen-activated protein kinase kinase 7 (MKK7), whereas the only other known JNK activator, mitogen-activated protein kinase kinase 4 (MKK4) In many nervous system disorders, including cerebral ischemia, traumatic brain injury and neurodegenerative diseases, overactivation of N-methyl-d-aspartate (NMDA) receptors leads to neuronal damage, resulting in neuronal loss and consequent severe neurological impairment. This cascade of neuronal injury, referred to as 'excitotoxicity', is still only partly understood. Dying neurons activate complex signal transduction events to trigger their death program, and the c-Jun N-terminal kinase (JNK) pathway plays an important role in this process. 1 D-retro-inverso form of JNK inhibitor (D-JNKI1) is an extremely potent neuroprotectant against excitotoxicity of cortical neurons and against different in vivo paradigms of neurodegeneration. [2][3][4] The active part of this peptide contains a retro-inverso form of a 20-amino-acid sequence (JBD 20 ) from the JNK-binding domain (JBD) of the scaffold protein JNK-interacting protein-1 (IB1/JIP-1), and it blocks the access of JNK to many of its targets. [5][6][7] Recently, Negri et al. 8,9 performed a detailed re-examination of the JBD-containing proteins and identified 19 different substrates of JNK. They then proved in a cell-free assay that the JBD 20 sequence prevented interactions and phosphorylations by JNK of nine of these targets. Among these nine substrates, we have studied the following four that might participate in regulating the death of cortical neurons: (1) MADD/DENN (MAPK-activating death domain-containing protein/differentially expressed in normal and neoplastic cells); (2-3) mitogen-activated protein kinase kinase 4 (MKK4) and mitogen-activated protein kinase kinase 7 (MKK7), the two direct upstream activators of JNK and (4) the scaffold protein IB1/JIP-1.,In particularly, MADD/DENN was identified as a substrate for JNK3, 10 the isoform most clearly involved in excitotoxicity 11,12 and mostly expressed in the brain. [10][11][12] Increasing evidence supports a strong correlation between low MADD/ DENN expression and neuronal loss. 13,14 MKK4 and MKK7 are the only known JNK activators. In some cell types, MKK4 activates JNK primarily by stress stimuli and MKK7 by inflammatory cytoki...

show abstract

A critical role of neural-specific JNK3 for ischemic apoptosis

Cited by 374 publications

References 46 publications

In vivoContributions of BH3-Only Proteins to Neuronal Death Following Seizures, Ischemia, and Traumatic Brain Injury

In vivoContributions of BH3-Only Proteins to Neuronal Death Following Seizures, Ischemia, and Traumatic Brain Injury

Possible role of spinal astrocytes in maintaining chronic pain sensitization: review of current evidence with focus on bFGF/JNK pathway

Role of the JNK pathway in NMDA-mediated excitotoxicity of cortical neurons

Contact Info

Product

Resources

About